Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: AÂ systematic review and meta-analysis

The addition of HIPEC to CRS and chemotherapy improves overall survival rates for both primary and recurrent EOC.